|
[1]
|
曹毛毛, 李贺, 孙殿钦, 何思怡, 杨帆, 严鑫鑫, 张绍丽, 夏昌发, 陈万青. 全球肝癌2020年流行病学现状[J]. 中华肿瘤防治杂志, 2022, 29(5): 322-328. [Google Scholar] [CrossRef]
|
|
[2]
|
Luo, W., et al. (2017) Effects of Radiofrequency Ablation versus Other Ablating Techniques on Hepatocellular Carcinomas: A System-atic Review and Meta-Analysis. World Journal of Surgical Oncology, 15, 126. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
杨薇, 梁梓南. 肝癌射频消融治疗的临床应用现状与进展[J]. 中华医学超声杂志(电子版), 2020, 17(4): 289-295.
|
|
[4]
|
杨曌, 谢辉, 王权, 张弢, 王华明, 何卫平, 段学章. 射波刀与射频消融治疗小肝癌的近期效果比较[J]. 临床肝胆病杂志, 2019, 35(9): 1965-1969.
|
|
[5]
|
Li, X.C., et al. (2019) Laparoscopic Hepatectomy versus Radiofrequency Ablation for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Cancer Management and Research, 11, 5711-5724. [Google Scholar] [CrossRef]
|
|
[6]
|
Liu, W., Xu, H., Ying, X., Zhang, D., Lai, L., Wang, L., Tu, J. and Ji, J. (2020) Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Pa-tients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome. Medical Sci-ence Monitor: International Medical Journal of Experimental and Clinical Research, 26, e923263. [Google Scholar] [CrossRef]
|
|
[7]
|
Chu, H.H., Kim, J.H., Yoon, H.K., et al. (2019) Chemoembolization Combined with Radiofrequency Ablation for Medium-Sized Hepatocellular Carcinoma: A Propensity-Score Analysis. Journal of Vascular and Interventional Radiology, 30, 1533-1543. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Wei, Y., et al. (2018) Impact of Local Tumor Lesion Treatments and Preoperative Indicators on the Survival of Patients with Small Hepatocellular Carcinomas. Oncology Letters, 1, 227-229. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Wang, X.D., et al. (2013) Margin Size Is an Independent Predictor of Local Tumor Progression after Ablation of Colon Cancer Liver Metastases. CardioVascular and Interventional Radiolo-gy, 36, 166-175. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
李广俊, 蔡日, 游焜. 经皮微波消融治疗中晚期肝癌的疗效观察[J]. 安徽医学, 2021, 42(6): 669-674.
|
|
[11]
|
崔姗姗, 姚志勇, 蒋玲玲. 超声引导下经皮微波消融联合胸腺素-α1治疗原发性肝癌的临床分析[J]. 影像研究与医学应用, 2020, 4(4): 142-143.
|
|
[12]
|
Leuchte, K., Staib, E., Thelen, M., et al. (2021) Microwave Ablation Enhances Tumor-Specific Immune Response in Patients with Hepatocellular Carcino-ma. Cancer Immunology, Immunotherapy, 70, 893-907. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
陈亚峰, 李江斌, 钟文钧, 董瑞, 臧莉, 阴继凯, 杜锡林, 鲁建国. 腹腔镜微波消融治疗≤3 cm肝细胞肝癌的临床疗效分析[J]. 中华腔镜外科杂志(电子版), 2021, 14(5): 271-276.
|
|
[14]
|
Li, H.Z., Tan, J., Tang, T., et al. (2021) Chemoembolization plus Microwave Ablation vs Chemoemboli-zation Alone in Unresectable Hepatocellular Carcinoma beyond the Milan Criteria: A Propensity Scoring Matching Study. Journal of Hepatocellular Carcinoma, 8, 1311-1322. [Google Scholar] [CrossRef]
|
|
[15]
|
Liu, C., Li, T., He, J.T. and Shao, H. (2020) TACE Combined with Microwave Ablation Therapy vs. TACE Alone for Treatment of Early- and Intermediate-Stage Hepatocellular Carcinomas Larger than 5 cm: A Meta-Analysis. Diagnostic and Interventional Radiology, 26, 575-583. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Sidana, A. (2014) Cancer Immunotherapy Using Tumor Cryoablation. Immunotherapy, 6, 85-93. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
格桑罗布, 等. 冷冻消融治疗肝细胞癌的研究进展[J]. 临床放射学杂志, 2021, 40(2): 397-400. [Google Scholar] [CrossRef]
|
|
[18]
|
Wang, C., Wang, H., Yang, W., et al. (2015) Multicenter Randomized Controlled Trial of Percutaneous Cryoablation versus Radiofrequency Ablation in Hepatocellular Carcinoma. Hepatology, 61, 1579-1590. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Ei, S., Hibi, T., Tanabe, M., et al. (2015) Cryoablation Provides Superior Local Control of Primary Hepatocellular Carcinomas of >2 cm Compared with Radiofrequency Ablation and Microwave Coagulation Therapy: An Underestimated Tool in the Toolbox. Annals of Surgical Oncology, 22, 1294-1300. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Yakkala, C., Chiang, C.L., Kandalaft, L., Denys, A. and Duran, R. (2019) Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors. Frontiers in Immunology, 10, 2283. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
EASL (2018) Clinical Practice Guidelines: Management of Hepatocellular Carcinoma. Journal of Hepatology, 69, 182-236. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Cucchetti, A., Serenari, M., Sposito, C., et al. (2020) Including mRECIST in the Metroticket 2.0 Criteria Improves Prediction of Hepa-tocellular Carcinoma-Related Death after Liver Transplant. Journal of Hepatology, 73, 342-348. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Pompili, M., De Matthaeis, N., Saviano, A., et al. (2015) Single Hepatocellular Carcinoma Smaller than 2 cm: Are Ethanol Injection and Radiofrequency Ablation Equally Effective? An-ticancer Research, 35, 325-332.
|
|
[25]
|
乔伟. 聚焦超声激励无水酒精增强肝肿瘤消融效果的实验研究[D]: [博士学位论文]. 重庆: 中国人民解放军陆军军医大学, 2020.[CrossRef]
|
|
[26]
|
Shiina, S., Sato, K., Tateishi, R., et al. (2018) Percutane-ous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery. Canadian Jour-nal of Gastroenterology and Hepatology, 2018, Article ID: 4756147. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
陈诚, 王俊杰, 吴涯昆. 高强度聚焦超声在中晚期肝癌中的临床应用进展[J]. 肝胆胰外科杂志, 2021, 33(12): 765-768+775.
|
|
[28]
|
Siedek, F., Yeo, S.Y., Heijman, E., et al. (2019) Magnetic Resonance-Guided High-Intensity Fo-cused Ultrasound (MR-HIFU): Technical Background and Overview of Current Clinical Applications (Part 1). Rofo, 191, 522-530. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Ma, B.F., et al. (2019) The Effect of High Intensity Focused Ultrasound on the Treatment of Liver Cancer and Patients’ Immunity. Cancer Biomarkers, 24, 85-90. [Google Scholar] [CrossRef]
|
|
[30]
|
李捷, 郭文治, 赵永福, 吴阳, 张水军. 高强度聚焦超声、氩氦刀冷冻消融及射频消融治疗小肝癌疗效对比[J]. 中华肝脏外科手术学电子杂志, 2019, 8(2): 133-138.
|
|
[31]
|
徐志宾, 高万勤. 原发性肝癌多种微创疗法的对比研究及临床应用[J]. 实用放射学杂志, 2008(6): 833-836.
|
|
[32]
|
黄真辉, 聂生东. 经皮激光消融技术应用研究进展[J]. 生物医学工程学进展, 2014, 35(4): 228-232.
|
|
[33]
|
Adwan, H., Vogl, T.J., Balaban, Ü. and Nour-Eldin, N.A. (2022) Percutaneous Thermal Ablation Therapy of Hepatocellular Carcinoma (HCC): Microwave Ablation (MWA) versus Laser-Induced Thermotherapy (LITT). Diagnostics (Basel), 12, 564. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
熊琨, 陈丹妮, 白飞, 魏雪峰, 林夏, 薛迪. 原发性肝癌激光消融的有效性和安全性初步评估[J]. 肝脏, 2018, 23(9): 782-785. [Google Scholar] [CrossRef]
|
|
[35]
|
伍晓敏, 周平, 马树花, 田双明, 邓金, 赵永峰. 超声引导下激光消融治疗高危部位小肝癌[J]. 南方医科大学学报, 2016, 36(1): 120-125.
|
|
[36]
|
Blazevski, A., Scheltema, M.J., Amin, A., et al. (2020) Irreversible Electroporation (IRE): A Narrative Review of the Development of IRE from the Laboratory to a Prostate Cancer Treatment. BJU International, 125, 369-378. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Bäumler, W., Beyer, L.P., Lürken, L., et al. (2022) Detection of Incomplete Irreversible Electroporation (IRE) and Microwave Ablation (MWA) of Hepatocellular Carcinoma (HCC) Using Iodine Quantification in Dual Energy Computed Tomography (DECT). Diagnostics (Basel), 12, 986. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Lahat, E., Eshkenazy, R., Zendel, A., et al. (2014) Complications after Percutaneous Ablation of Liver Tumors: A Systematic Review. Hepatobiliary Surgery and Nutrition, 3, 317-323.
|
|
[39]
|
Mafeld, S., Wong, J.J., Kibriya, N., et al. (2019) Percutaneous Irreversible Electroporation (IRE) of He-patic Malignancy: A Bi-Institutional Analysis of Safety and Outcomes. CardioVascular and Interventional Radiology, 42, 577-583. [Google Scholar] [CrossRef] [PubMed]
|